- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05616611
High-Intensity Laser Therapy Versus Shockwave Therapy in Osteoporotic Long Term Hemiparetic Patients
High-Intensity Laser Therapy Versus Shockwave Therapy on Selected Outcome Measures in Osteoporotic Long Term Hemiparetic Patients: A Randomized Control Trial
Background: The relationship between immobilization and localized osteoporosis is well documented in chronic stroke patients. Hemiparetic patients are predisposed to fractures and usual activity impairment due to a considerable loss of bone density. A serious health care challenge is finding ways to reduce osteoporosis and associated fractures among stroke survivors. This study aimed to compare the effects of HILT and ESWT in treating osteoporosis and its consequences in hemiparetic patients.
Patients and Methods: A randomized controlled trial was performed at the Faculty of Physical Therapy Outpatient Clinic, Cairo University. One hundred and twenty hemiplegic patients with osteoporosis of both sexes were chosen randomly. They were randomly classified into three equal groups (n=40 in each group). The control group received medication and traditional physiotherapy programs for stroke patients (strengthening, stretching, and balance exercise). The high-intensity laser (HIL) group received the same intervention as the control group in addition to high-intensity laser therapy. The shock wave (SW) group received the same intervention as the control group in addition to shock wave therapy. The three groups received an intervention that lasted 3 sessions/week for 12 weeks). All groups were assessed before and after therapy (3 months) for the degree of pain, which was evaluated by visual analog scale (VAS), fall risk assessment (overall stability index and Short Form of Berg Balance Scale (SFBBS)), and Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Sharq
-
Banī Suwayf, Sharq, Egypt, 11222
- Beni-Suef University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All participants were diagnosed by Dual-energy X-ray absorptiometry (DEXA) as osteoporosis or osteopenia, where T-score was -1.5 or less.
- All patients were recruited from Kasr Al-Ainy Hospital, Cairo University.
Exclusion Criteria:
- BMI of more than 30 or less than 18
- Advanced musculoskeletal disorders.
- Rheumatoid arthritis.
- Skin diseases.
- Long-term steroids therapy, or any drug affecting bones.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control group
control group received medication and traditional physiotherapy programs for stroke patients (strengthening, stretching, and balance exercise)
|
intervention that lasted 3 sessions/week for 12 weeks).
|
|
Experimental: high-intensity laser group
The high-intensity laser (HIL) group received the same intervention as the control group in addition to high-intensity laser therapy.
|
intervention that lasted 3 sessions/week for 12 weeks).
|
|
Experimental: shock wave group
shock wave (SW) group received the same intervention as the control group in addition to shock wave therapy.
|
intervention that lasted 3 sessions/week for 12 weeks).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41)
Time Frame: 12 weeks
|
Quality of Life Questionnaire of the European Foundation for Osteoporosis
|
12 weeks
|
|
Pain intensity
Time Frame: 12 weeks
|
Visual analogue scale, a scale of 10 poi to 0 represent no pain at all and 10 represent the worst pain
|
12 weeks
|
|
fall risk assessment
Time Frame: 12 weeks
|
Short Form of Berg Balance Scale ,(SFBBS) ranged from 0 poor balance to 28 good balance.consisted of 7 items each item has grades from 1 poor balance to 4 good balance
|
12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Mohamed A Adel, Mr, Beni-Suef University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BeniSuefU1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoporosis Secondary
-
Regina Elena Cancer InstituteRecruitingBreast Cancer Females | Osteoporosis SecondaryItaly
-
University of GuadalajaraHospital Civil de GuadalajaraCompleted
-
Odense University HospitalUniversity of Ulm; University of Birmingham; Esbjerg Hospital - University Hospital...Active, not recruitingOsteoporosis SecondaryDenmark
-
Ankara Etlik City HospitalRecruitingAxillary Web Syndrome | Shoulder Adhesive Capsulitis | Postmastectomy Lymphedema Syndrome | Osteoporosis Secondary | Breast Cancer Surgery PainTurkey (Türkiye)
-
Creighton UniversityGlaxoSmithKlineCompletedOsteoporosis | Secondary Hyperparathyroidism
-
Hospital Regional 1o de OctubreUniversidad Nacional Autonoma de Mexico; National Polytechnic Institute, MexicoCompletedHyperparathyroidism, Primary | Hyperparathyroidism, Secondary | Hypovitaminosis D | Postmenopause | Postmenopausal OsteoporosisMexico
-
Mayo ClinicCompletedMetabolic Bone Disease | Transplant-Related Disorder | Secondary OsteoporosisUnited States
-
Odense University HospitalAarhus University Hospital; Aalborg University Hospital; Hospital of South West... and other collaboratorsActive, not recruitingDiabetes Mellitus, Type 1 | Osteoporosis SecondaryDenmark
-
James J. Peters Veterans Affairs Medical CenterKessler Institute for RehabilitationTerminatedSpinal Cord Injury | Secondary OsteoporosisUnited States
-
Radius Health, Inc.CompletedOsteoporosis | Osteoporosis Risk | Osteoporosis, Postmenopausal | Osteoporosis Fracture | Osteoporosis, Age-Related | Osteoporosis Localized to Spine | Osteoporosis Senile | Osteoporosis of Vertebrae | Osteoporosis VertebralUnited States
Clinical Trials on Traditional physiotherapy exercises
-
Hacettepe UniversityCompleted
-
Cairo UniversityActive, not recruiting
-
Aliaa Altohamy GodaCompleted
-
McCarious Nahad Aziz Abdelshaheed StephensCairo UniversityActive, not recruitingPost-COVID-19 Syndrome | Lung Fibrosis InterstitialEgypt
-
Uskudar UniversityCompletedCervical Disc HerniationTurkey
-
Superior UniversityActive, not recruiting
-
Isra UniversityCompletedMedial Compartment Knee OsteoarthritisPakistan
-
Pantelis SyringasUniversity of Ioannina; University of Peloponnese; Physioloft, Physiotherapy... and other collaboratorsCompletedStroke | Spasticity, Muscle | Upper Extremity DysfunctionGreece
-
University of BeykentCompletedPhysiotherapy | KinesiotapingTurkey
-
Region ÖstergötlandLinkoeping UniversityNot yet recruitingShoulder Pain | Subacromial Pain Syndrome | Rotator Cuff SyndromeSweden